CMDBioscience is committed to accelerating peptide discovery through the use of computation. By employing our groundbreaking computational peptide discovery platform, CMDInventus, CMDBioscience can help partner companies solve their peptide drug discovery problems and build lasting value.
CMDBioscience seeks to build collaborative discovery projects with partners that can leverage CMDInventus and our expertise in computational chemistry and peptide drug discovery. By collaborating with CMDBioscience, partners can expect quality hits, novel leads and greater insight into their leads, in an efficient manner.
Built from the ground up specifically to help solve the peptide drug discovery problem, CMDInventus provides partner companies with unique access to all of the capabilities expected of a computational biotech company with a unique and targeted focus on peptides.
Copyright 2012: CMD Bioscience. Computational Biotechnology. All rights reserved.